| Pfizer AG - Talzenna 0.35 mg, Hartkapseln | | 67141 | | 04 | | Talzenna 0.35 mg | | Hartkapseln | | L01XK04 | | Talazoparib | | 12.07.2024 | | |
| | Composition | | talazoparibum 0.35 mg ut talazoparibi tosilas, cellulosum microcristallinum silicificatum, Kapselhülle: hypromellosum, E 171, E 172 (flavum), Drucktinte: lacca, propylenglycolum, ammonii hydroxidum, E 172 (nigrum), kalii hydroxidum, pro capsula. | | Packungsbestandteile | | Capsules | | | | Principe actif | Concentr. |
|---|
| Talazoparibum | 0.35 mg |
| | | | Agents auxilliaires | | informations additionels |
|---|
| (Flavum) | | | | (Nigrum) | | | | Ammonii Hydroxidum | | | | Cellulosum Microcristallinum Silicificatum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | Kapselhülle | | Kalii Hydroxidum | | | | Lacca | | Drucktinte | | Pro Capsula | | | | Propylenglycol | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 008 | 30 | DDP | DDP | A | | Non |
|
|
